Mitochondria-mediated cardiomyocyte apoptosis is involved in
myocardial ischemia/reperfusion (MI/R) injury.
Clematichinenoside (AR) is a
triterpenoid saponin isolated from the roots of Clematis chinensis with
antioxidant and anti-inflammatory cardioprotection effects against MI/R injury, yet the anti-apoptotic effect and underlying mechanisms of AR in MI/R injury remain unclear. We hypothesize that AR may improve mitochondrial function to inhibit MI/R-induced cardiomyocyte apoptosis. In this study, we replicated an in vitro H9c2 cardiomyocyte MI/R model by
hypoxia/reoxygenation (H/R) treatment. The viability of H9c2 cardiomyocytes was determined by MTT assay; apoptosis was evaluated by flow cytometry and TUNEL experiments;
mitochondrial permeability transition pore (mPTP) opening was analyzed by a
calcein-
cobalt quenching method; and mitochondrial membrane potential (ΔΨm) was detected by
JC-1. Moreover, we used western blots to determine the mitochondrial
cytochrome c translocation to cytosolic and the expression of
caspase-3, Bcl-2, and Bax
proteins. These results showed that the application of AR decreased the ratio of apoptosis and the extent of
mPTP opening, but increased ΔΨm. AR also inhibited H/R-induced release of mitochondrial
cytochrome c and decreased the expression of the
caspase-3, Bax
proteins. Conversely, it remarkably increased the expression of Bcl-2
protein. Taken together, these results revealed that AR protects H9c2 cardiomyocytes against H/R-induced apoptosis through mitochondrial-mediated apoptotic signaling pathway.